Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years.

Saved in:
Bibliographic Details
Title: Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years.
Authors: Repka MX, Kraker RT, Beck RW, Atkinson CS, Bacal DA, Bremer DL, Davis PL, Gearinger MD, Glaser SR, Hoover DL, Laby DM, Morrison DG, Rogers DL, Sala NA, Suh DW, Wheeler MB
Corporate Authors: Pediatric Eye Disease Investigator Group
Source: Archives of ophthalmology (Chicago, Ill. : 1960) [Arch Ophthalmol] 2010 Sep; Vol. 128 (9), pp. 1215-7.
Publication Type: Clinical Trial, Phase III; Comparative Study; Letter; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 7706534 Publication Model: Print Cited Medium: Internet ISSN: 1538-3601 (Electronic) Linking ISSN: 00039950 NLM ISO Abbreviation: Arch Ophthalmol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-3601
DOI:10.1001/archophthalmol.2010.178